Study backs efficacy of device for non-valvular atrial fibrillation
A study of non-valvular atrial fibrillation patients who received Watchman -- a device used to close the heart's left atrial appendage -- versus those who received long-term warfarin therapy was conducted to compare the chance of experiencing stroke, death caused by cardiovascular conditions and systemic embolisms. Although U.S. researchers found a higher rate of serious problems in the device group than in the warfarin group, they linked the adverse events in the device group to "periprocedural complications."
Yahoo! | 08/14
This story published in AdvaMed SmartBrief on 08/17/2009
Endoscopic Technologies settles claims
Wednesday, July 15, 2009
Report: More study needed on catheters for atrial fibrillation
Thursday, July 9, 2009
EU approves AtriCure's cardiac device
Wednesday, October 7, 2009
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|